Efferon CT
Efferon CT is a medical device with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis
Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction
Combination of Cytokine Hemosorption and High-volume Hemofiltration in Acute Pancreatitis
Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock
Hemoperfusion Efferon СT for the Treatment of Patients With Acute Pancreatitis
Clinical Trials (6)
Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis
Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction
Combination of Cytokine Hemosorption and High-volume Hemofiltration in Acute Pancreatitis
Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock
Hemoperfusion Efferon СT for the Treatment of Patients With Acute Pancreatitis
Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6